Novavax- Serum Institute Of India collaboration

Novavax seeks EUA for its COVID-19 vaccine in India

Stanley Erck, the Novavax CEO, termed the submissions an "important step toward access to millions of doses of a safe and effective vaccine for countries with an urgent need to control the pandemic."

SII to start clinical trials of Novavax COVID vaccine for kids in July

Serum Institute Of India and US’ Novavax to produce 100 crore doses against COVID-19

Serum Institute Of India and Us - based Novavax have entered in a deal. They may together produce 100 crore